NEW YORK (GenomeWeb News) – The Korean operations of Institut Pasteur and Sanofi-Aventis announced on Wednesday a collaboration to screen for new compounds directed at Hepatitis B.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.